Tessa L Steel1, Carol A Malte, Katharine A Bradley, Sharukh Lokhandwala, Catherine L Hough, Eric J Hawkins. 1. University of Washington, Division of Pulmonary, Critical Care, & Sleep Medicine, Seattle-Denver Center of Innovation (COIN), VA Puget Sound Health Care System, Seattle Division, Seattle, WA (TLS); Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle Division, Seattle, WA (CAM); Kaiser Permanente Washington Health Research Institute, Seattle, WA (KAB); University of Washington, Division of Pulmonary, Critical Care, & Sleep Medicine, Harborview Medical Center, Seattle, WA (SL, CLH); Center of Excellence in Substance Addiction Treatment and Education Seattle-Denver Center of Innovation (COIN), University of Washington, Department of Psychiatry and Behavioral Sciences, VA Puget Sound Health Care System, Seattle Division, Seattle, WA (EJH).
Abstract
OBJECTIVES: No prior study has evaluated the prevalence or variability of alcohol withdrawal syndrome (AWS) in general hospitals in the United States. METHODS: This retrospective study used secondary data from the Veterans Health Administration (VHA) to estimate the documented prevalence of clinically recognized AWS among patients engaged in VHA care who were hospitalized during fiscal year 2013. We describe variation in documented inpatient AWS by geographic region, hospital, admitting specialty, and inpatient diagnoses using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis and/or procedure codes recorded at hospital admission, transfer, or discharge. RESULTS: Among 469,082 eligible hospitalizations, the national prevalence of documented inpatient AWS was 5.8% (95% confidence interval [CI] 5.2%-6.4%), but there was marked variation by geographic region (4.3%-11.2%), hospital (1.4%-16.1%), admitting specialty (0.7%-19.0%), and comorbid diagnoses (1.3%-38.3%). AWS affected a high proportion of psychiatric admissions (19.0%, 95% CI 17.5%-20.4%) versus Medical (4.4%, 95% CI 4.0%-4.8%) or surgical (0.7%, 95% CI 0.6%-0.8%); though by volume, medical admissions represented the majority of hospitalizations complicated by AWS (n = 13,478 medical versus n = 12,305 psychiatric and n = 595 surgical). Clinically recognized AWS was also common during hospitalizations involving other alcohol-related disorders (38.3%, 95% CI 35.8%-40.8%), other substance use conditions (19.3%, 95% CI 17.7%-20.9%), attempted suicide (15.3%, 95% CI 13.0%-17.6%), and liver injury (13.9%, 95% CI 12.6%-15.1%). CONCLUSIONS: AWS was commonly recognized and documented during VHA hospitalizations in 2013, but varied considerably across inpatient settings. This clinical variation may, in part, reflect differences in quality of care and warrants further, more rigorous investigation.
OBJECTIVES: No prior study has evaluated the prevalence or variability of alcohol withdrawal syndrome (AWS) in general hospitals in the United States. METHODS: This retrospective study used secondary data from the Veterans Health Administration (VHA) to estimate the documented prevalence of clinically recognized AWS among patients engaged in VHA care who were hospitalized during fiscal year 2013. We describe variation in documented inpatient AWS by geographic region, hospital, admitting specialty, and inpatient diagnoses using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis and/or procedure codes recorded at hospital admission, transfer, or discharge. RESULTS: Among 469,082 eligible hospitalizations, the national prevalence of documented inpatient AWS was 5.8% (95% confidence interval [CI] 5.2%-6.4%), but there was marked variation by geographic region (4.3%-11.2%), hospital (1.4%-16.1%), admitting specialty (0.7%-19.0%), and comorbid diagnoses (1.3%-38.3%). AWS affected a high proportion of psychiatric admissions (19.0%, 95% CI 17.5%-20.4%) versus Medical (4.4%, 95% CI 4.0%-4.8%) or surgical (0.7%, 95% CI 0.6%-0.8%); though by volume, medical admissions represented the majority of hospitalizations complicated by AWS (n = 13,478 medical versus n = 12,305 psychiatric and n = 595 surgical). Clinically recognized AWS was also common during hospitalizations involving other alcohol-related disorders (38.3%, 95% CI 35.8%-40.8%), other substance use conditions (19.3%, 95% CI 17.7%-20.9%), attempted suicide (15.3%, 95% CI 13.0%-17.6%), and liver injury (13.9%, 95% CI 12.6%-15.1%). CONCLUSIONS:AWS was commonly recognized and documented during VHA hospitalizations in 2013, but varied considerably across inpatient settings. This clinical variation may, in part, reflect differences in quality of care and warrants further, more rigorous investigation.
Authors: James M O'Brien; Bo Lu; Naeem A Ali; Greg S Martin; Scott K Aberegg; Clay B Marsh; Stanley Lemeshow; Ivor S Douglas Journal: Crit Care Med Date: 2007-02 Impact factor: 7.598
Authors: José R Maldonado; Yelizaveta Sher; Judith F Ashouri; Kelsey Hills-Evans; Heavenly Swendsen; Sermsak Lolak; Anne Catherine Miller Journal: Alcohol Date: 2014-02-19 Impact factor: 2.405
Authors: Katharine A Bradley; Emily C Williams; Carol E Achtmeyer; Bryan Volpp; Bonny J Collins; Daniel R Kivlahan Journal: Am J Manag Care Date: 2006-10 Impact factor: 2.229
Authors: C D Spies; A Nordmann; G Brummer; C Marks; C Conrad; G Berger; N Runkel; T Neumann; C Müller; H Rommelspacher; M Specht; L Hannemann; H W Striebel; W Schaffartzik Journal: Acta Anaesthesiol Scand Date: 1996-07 Impact factor: 2.105
Authors: Brendan J Clark; Angela Keniston; Ivor S Douglas; Thomas Beresford; Madison Macht; Andre Williams; Jacqueline Jones; Ellen L Burnham; Marc Moss Journal: Alcohol Clin Exp Res Date: 2013-05-03 Impact factor: 3.455
Authors: Joshua T Smith; Mary Sage; Herb Szeto; Laura C Myers; Yun Lu; Adriana Martinez; Patricia Kipnis; Vincent X Liu Journal: JAMA Netw Open Date: 2022-02-01
Authors: Juan Antonio Suárez-Cuenca; Christian Gabriel Toledo-Lozano; Maryjose Daniela Espinosa-Arroyo; Nallely Alejandra Vázquez-Aguirre; Gandhy Thomas Fonseca-González; Karen Garro-Almendaro; Alberto Melchor-López; Victor Hugo García-López; Abril Ortiz-Matamoros; Tania Ortega-Rosas; Sofia Lizeth Alcaraz-Estrada; Paul Mondragón-Terán; Silvia García Journal: Int J Environ Res Public Health Date: 2022-07-28 Impact factor: 4.614
Authors: Tessa L Steel; Majid Afshar; Scott Edwards; Sarah E Jolley; Christine Timko; Brendan J Clark; Ivor S Douglas; Amy L Dzierba; Hayley B Gershengorn; Nicholas W Gilpin; Dwayne W Godwin; Catherine L Hough; José R Maldonado; Anuj B Mehta; Lewis S Nelson; Mayur B Patel; Darius A Rastegar; Joanna L Stollings; Boris Tabakoff; Judith A Tate; Adrian Wong; Ellen L Burnham Journal: Am J Respir Crit Care Med Date: 2021-10-01 Impact factor: 21.405